These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10919077)

  • 1. Design and synthesis of melatonin receptors agonists and antagonists.
    Tarzia G; Diamantini G; Mor M; Spadoni G
    Farmaco; 2000 Mar; 55(3):184-7. PubMed ID: 10919077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.
    Spadoni G; Balsamini C; Bedini A; Diamantini G; Di Giacomo B; Tontini A; Tarzia G; Mor M; Plazzi PV; Rivara S; Nonno R; Pannacci M; Lucini V; Fraschini F; Stankov BM
    J Med Chem; 1998 Sep; 41(19):3624-34. PubMed ID: 9733487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
    J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole melatonin agonists and antagonists derived by shifting the melatonin side chain from the C-3 to the N-1 or to the C-2 indole position.
    Tarzia G; Diamantini G; Spadoni G
    Biol Signals Recept; 1999; 8(1-2):24-31. PubMed ID: 10085459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
    Teh MT; Sugden D
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists.
    Tsotinis A; Vlachou M; Eleutheriades A; Prinea E; Ebreo D; The MT; Sugden D
    Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):31-9. PubMed ID: 11824582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
    Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
    J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydronaphthalenic derivatives as new agonist and antagonist ligands for melatonin receptors.
    Fourmaintraux E; Depreux P; Lesieur D; Guardiola-Lemaître B; Bennejean C; Delagrange P; Howell HE
    Bioorg Med Chem; 1998 Jan; 6(1):9-13. PubMed ID: 9502101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
    Tsotinis A; Eleutheriades A; Hough K; Sugden D
    Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.
    Dubocovich ML; Masana MI; Iacob S; Sauri DM
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):365-75. PubMed ID: 9089668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
    Descamps-François C; Yous S; Chavatte P; Audinot V; Bonnaud A; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
    J Med Chem; 2003 Mar; 46(7):1127-9. PubMed ID: 12646022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of subtype selective melatonin receptor agonists and antagonists.
    Sugden D; Yeh LK; Teh MT
    Reprod Nutr Dev; 1999; 39(3):335-44. PubMed ID: 10420436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
    Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
    J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
    Wallez V; Durieux-Poissonnier S; Chavatte P; Boutin JA; Audinot V; Nicolas JP; Bennejean C; Delagrange P; Renard P; Lesieur D
    J Med Chem; 2002 Jun; 45(13):2788-800. PubMed ID: 12061881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines.
    Garratt PJ; Jones R; Tocher DA; Sugden D
    J Med Chem; 1995 Mar; 38(7):1132-9. PubMed ID: 7707316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.
    Mathé-Allainmat M; Le Gall M; Jellimann C; Andrieux J; Langlois M
    Bioorg Med Chem; 1999 Dec; 7(12):2945-52. PubMed ID: 10658600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-affinity relationships of indole-based melatonin analogs.
    Spadoni G; Mor M; Tarzia G
    Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells.
    Nonno R; Lucini V; Pannacci M; Mazzucchelli C; Angeloni D; Fraschini F; Stankov BM
    Br J Pharmacol; 1998 Jun; 124(3):485-92. PubMed ID: 9647472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
    Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
    J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.
    Spadoni G; Balsamini C; Diamantini G; Tontini A; Tarzia G; Mor M; Rivara S; Plazzi PV; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
    J Med Chem; 2001 Aug; 44(18):2900-12. PubMed ID: 11520198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.